Spiro-cyclic &bgr;-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-&agr; converting enzyme (TACE)
申请人:Bristol-Myers Squibb Pharma
公开号:US06720329B2
公开(公告)日:2004-04-13
The present application describes novel spiro-cyclic &bgr;-amino acid derivatives of formula I:
or pharmaceutically acceptable salt forms thereof, wherein ring B is a 3-13 membered carbocycle or heterocycle, ring C forms a 3-11 membered spiro-carbocycle or spiro-heterocycleon ring B, and the other variables are defined in the present specification, which are useful as as matrix metalloproteinases (MMP), TNF-&agr; converting enzyme (TACE), and/or aggrecanase inhibitors.
本申请描述了新型螺环状&bgr;-氨基酸衍生物的公式I:或其药学上可接受的盐形式,其中环B是3-13成员的碳环或杂环,环C在环B上形成3-11成员的螺环状碳环或螺环状杂环,而其他变量在本说明书中定义,这些衍生物可用作基质金属蛋白酶(MMP)、TNF-&agr;转化酶(TACE)和/或聚集素酶抑制剂。